2022
DOI: 10.1063/5.0073494
|View full text |Cite
|
Sign up to set email alerts
|

Performance of nanoparticles for biomedical applications: The in vitro/in vivo discrepancy

Abstract: Nanomedicine has a great potential to revolutionize the therapeutic landscape. However, up-to-date results obtained from in vitro experiments predict the in vivo performance of nanoparticles weakly or not at all. There is a need for in vitro experiments that better resemble the in vivo reality. As a result, animal experiments can be reduced, and potent in vivo candidates will not be missed. It is important to gain a deeper knowledge about nanoparticle characteristics in physiological environment. In this conte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 339 publications
0
9
0
Order By: Relevance
“…142,146,147 Moreover, because specific antibodies can be attached to the surface of graphene-based nanoforms, several voltammetric biomarkers have also been constructed, reported to be suitable in medical diagnostics. [148][149][150] From most of the voltammetric studies presented so far, it seems that the future of voltammetry will be closely linked to the further development of current and novel forms of various nanoparticles.…”
Section: Resultsmentioning
confidence: 99%
“…142,146,147 Moreover, because specific antibodies can be attached to the surface of graphene-based nanoforms, several voltammetric biomarkers have also been constructed, reported to be suitable in medical diagnostics. [148][149][150] From most of the voltammetric studies presented so far, it seems that the future of voltammetry will be closely linked to the further development of current and novel forms of various nanoparticles.…”
Section: Resultsmentioning
confidence: 99%
“…1 Nonviral carriers for the delivery of different nucleic acids, including their main components, particle types as well as shielding and targeting agents for organ-or cell-specific delivery upon systemic injection. Created with BioRender.com nanocarriers, however, are confronted with blood components like plasma proteins that adsorb on particle surface and hence sustainably affect circulation, transport to tissues and cellular uptake [38][39][40]. For instance, the formation of a protein corona comprised of opsonins will mediate phagocytosis removing particles from the circulation.…”
Section: Shieldingmentioning
confidence: 99%
“…Potential reasons for this observation must be considered and evaluated in order to find explanations for this translational bottleneck. There is a great discrepancy between the results obtained from in vitro studies and in vivo performance, making predictions for (pre-)clinical studies questionable when drawn from cell culture evaluation [38][39][40].…”
Section: Active Targeting: In Vitro Versus In Vivomentioning
confidence: 99%
“…In the last decade, accumulated evidence about the importance of the stem cell microenvironment in modeling human tissue in vitro led to a transition from 2D to 3D culture (Caswell and Zech, 2018;Ingber, 2020;Jensen and Teng, 2020;Dudaryeva et al, 2021;Indana et al, 2021;Jacchetti et al, 2021;Berger et al, 2022). As compared to conventional planar models, 3D systems add a new layer of biological relevance by recapitulating 3D tissue complexity and structural organizations, including critical cell-to-cell and cell-matrix interactions (Birgersdotter et al, 2005;Anselme et al, 2018;Jensen and Teng, 2020;Dudaryeva et al, 2021;Yamada et al, 2022).…”
Section: Introductionmentioning
confidence: 99%